We are live on ! Find out more
CYPH

Cypherpunk Technologies Inc

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%

Neutral
PRNewsWire
1 day ago
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026.
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
Neutral
PRNewsWire
1 day ago
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapy CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (Nasdaq: CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Neutral
Seeking Alpha
1 month ago
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript
Neutral
PRNewsWire
3 months ago
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026.
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
Neutral
PRNewsWire
4 months ago
Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard
CAMBRIDGE, Mass., April 15, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced its latest purchase of 9,163.32 ZEC for $2,150,000 at an average purchase price of $234.63 per ZEC and launched its new website and investor dashboard at cypherpunk.com.
Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard
Neutral
PRNewsWire
5 months ago
Cypherpunk Reports Full Year 2025 Financial Results
CAMBRIDGE, Mass., March 16, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the year ended December 31, 2025.
Cypherpunk Reports Full Year 2025 Financial Results
Neutral
PRNewsWire
5 months ago
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)
Cypherpunk expands its holdings with new $5M investment in Zcash company, ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg , Balaji Srinivasan, and others CAMBRIDGE, Mass., March 9, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced the company has invested $5M into Zcash Open Development Lab (ZODL) marking its first technology investment outside of ZEC.
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)
Neutral
PRNewsWire
6 months ago
Cypherpunk Adds Arjun Khemani as Strategic Advisor
CAMBRIDGE, Mass., Jan. 22, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy technology company, today announced that Arjun Khemani has joined the company as a Strategic Advisor.
Cypherpunk Adds Arjun Khemani as Strategic Advisor
Neutral
PRNewsWire
7 months ago
Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor
CAMBRIDGE, Mass. , Dec. 19, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that Josh Swihart, Chief Executive Officer of Electric Coin Company (ECC), has joined the company as a Strategic Advisor.
Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor
Neutral
Seeking Alpha
8 months ago
Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript